Merja R. Häkkinen
Papers
1
Total Citations
87
H-Index
1
About
Dr. Merja R. Häkkinen is a pioneering researcher in the field of biomedical diagnostics, with a primary focus on the development of non-invasive, rapid screening technologies for urological cancers. Her most significant contribution lies in the application of electronic nose (eNose) technology for cancer detection, a breakthrough that marries sensor engineering with clinical oncology. Her landmark 2014 study, "Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study," which has garnered 87 citations, demonstrated the ability of the ChemPro® 100-eNose to discriminate between prostate cancer and benign prostatic hyperplasia by analyzing volatile organic compounds in urine headspace. This work established a clinically applicable, noninvasive diagnostic method that could dramatically reduce unnecessary biopsies. Dr. Häkkinen’s research is characterized by its translational impact, bridging the gap between laboratory innovation and practical clinical utility. Her achievements have positioned her as a key figure in the emerging field of volatile metabolomics, offering a promising alternative to traditional invasive diagnostic procedures.
Research Focus
Key Achievements
Top Papers
- 1